And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Under the circumstances, our agenda is decidedly modest. We plan to connect with some people using the latest technologies from the safety of our castle, promenade our new official mascot, and catch up on some reading. And what about you? This may be a good time to get a head start on spring cleaning. You could reach out to an older person who might welcome a little interaction. Or you could simply take the long view and imagine how the world is changing. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon.
Roche (RHHBY) is unable to meet demand for coronavirus testing kits but is unwilling to share key information with labs to help them carry out mass testing, Dutch News writes, citing Follow The Money. Most Dutch testing labs work with Roche equipment and depend on the company for supplies and, due to special deals known as a “vendor lock-in,” they are not able to turn to alternative sources to stock up on essential items. The shortage of a liquid used to break open cells is one reason why the Netherlands is not carrying out mass testing.
About the Author Reprints
If I recall Mr Trumps quote correctly (from last evening on Fox?), “There is no risk in using a drug that’s already approved.” Taken literally, as well as seriously, the results from the misuse of acetominaphine (aka the venerable Tylenol) would seem to contradict him.
Ignore the known side effects and the fact that the best ‘anecdotally reported results’ were combined with another drug that needs to be used carefully, and caution is warranted. Hopefully, the results from the observational studies in NYC hospitals will provide positive results – but I suspect this will be an 80 pct solution at best, rather than “a miracle.” [ Note: If the President can say he’s “guessing but …” I can say I suspect. ]